Phase I Dose Escalation Trial of Efavirenz in Solid Tumours or Non-Hodgkin Lymphoma in Therapeutic Failure.
Clinical trial NCT01878890 · COMPLETED
Trial details
- NCT number
- NCT01878890
- Sponsor
- Institut Bergonié
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-05
- Primary completion
- 2014-09-16
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.